by PRI | May 31, 2023 | News & Events
The Delphi Survey on finding a consensus around the development and validation of microbiome-based biomarkers has launched its second round (of two). This second and final round will remain open until the end of the day on June 6th. The second round of the Delphi...
by PRI | May 16, 2023 | Microbiome Clinical Research (CRO), Other Expertise | Quality, Legal, IP, Regulatory Affairs, Management
Clara Desvignes Director, Drugs, Medical Devices & Microbiome-based products VCLS collaborates with developers to strategically position their microbiome-based products, creating a roadmap to hit product development milestone, and achieve the commercial success....
by PRI | Apr 19, 2023 | News & Events
In June 2021, the European Pharmacopeia Commission (EDC) chose to embark upon the drafting of a new general chapter on phage therapy active substances and medicinal products for both human and veterinary use. The Bacteriophages Working Party was tasked with the...
by PRI | Apr 9, 2023 | News & Events
UPDATE (07/04/23) The Delphi Survey on finding a consensus around the development and validation of microbiome-based biomarkers is almost closed! The Survey platform will be open to accept submissions until 10 April. Once the platform closes, the responses will be...
by PRI | Mar 28, 2023 | News & Events
Last week over 220 attendees joined together in Lyon, France for the 8th annual Pharmabiotics Conference & Partnering event. The 2023 edition focused on the main theme of ‘The Future of Microbiome-based Medicinal Products’, and brought together research and...
